Ceramide signaling in the coronary microcirculation: a double-edged sword?
作者信息
Weil Brian R, Canty John M
机构信息
From the Departments of Medicine, Biomedical Engineering, and Physiology and Biophysics, The Veterans Affairs Western New York Healthcare System and the Clinical and Translational Research Center at the University at Buffalo.
出版信息
Circ Res. 2014 Aug 15;115(5):475-7. doi: 10.1161/CIRCRESAHA.114.304589.
Abstract
摘要
相似文献
1
Ceramide signaling in the coronary microcirculation: a double-edged sword?
Circ Res. 2014 Aug 15;115(5):475-7. doi: 10.1161/CIRCRESAHA.114.304589.
2
Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation.
Circ Res. 2014 Aug 15;115(5):525-32. doi: 10.1161/CIRCRESAHA.115.303881. Epub 2014 Jun 11.
3
Manipulation of the Sphingolipid Rheostat Influences the Mediator of Flow-Induced Dilation in the Human Microvasculature.
J Am Heart Assoc. 2019 Sep 3;8(17):e013153. doi: 10.1161/JAHA.119.013153. Epub 2019 Aug 29.
4
Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs in vivo.
J Am Coll Cardiol. 2007 Sep 25;50(13):1272-8. doi: 10.1016/j.jacc.2007.05.039. Epub 2007 Sep 10.
5
Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase.
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1254-62. doi: 10.1161/ATVBAHA.116.307518. Epub 2016 Apr 14.
6
Hypertension preserves the magnitude of microvascular flow-mediated dilation following transient elevation in intraluminal pressure.
Physiol Rep. 2021 Feb;9(3):e14507. doi: 10.14814/phy2.14507.
7
Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries.
Circ Res. 2001 Apr 27;88(8):824-31. doi: 10.1161/hh0801.089604.
8
The human coronary vasodilatory response to acute mental stress is mediated by neuronal nitric oxide synthase.
Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H578-H583. doi: 10.1152/ajpheart.00745.2016. Epub 2017 Jun 23.
9
Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
Cardiovasc Diabetol. 2013 Aug 1;12:111. doi: 10.1186/1475-2840-12-111.
10
Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo.
Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1138-46. doi: 10.1152/ajpheart.00187.2006. Epub 2006 Apr 28.
引用本文的文献
1
Ceramide in Coronary Artery Disease: Troublesome or Helpful Future Tools in the Assessment of Risk Prediction and Therapy Effectiveness?
Metabolites. 2025 Mar 1;15(3):168. doi: 10.3390/metabo15030168.
2
Ceramides and pro-inflammatory cytokines for the prediction of acute coronary syndrome: a multi-marker approach.
BMC Cardiovasc Disord. 2024 Jan 13;24(1):47. doi: 10.1186/s12872-023-03690-1.
3
Ablation of Sphingosine Kinase 1 Protects Cornea from Neovascularization in a Mouse Corneal Injury Model.
Cells. 2022 Sep 17;11(18):2914. doi: 10.3390/cells11182914.
4
Plasma Ceramide Levels Are Elevated in Patients With Early Coronary Atherosclerosis and Endothelial Dysfunction.
J Am Heart Assoc. 2022 Apr 5;11(7):e022852. doi: 10.1161/JAHA.121.022852. Epub 2022 Mar 18.
5
Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial.
ESC Heart Fail. 2020 Dec;7(6):3288-3297. doi: 10.1002/ehf2.12885. Epub 2020 Jul 6.
6
Impaired Peripheral Endothelial Function Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis.
J Am Heart Assoc. 2016 Jun 17;5(6):e003202. doi: 10.1161/JAHA.116.003202.
本文引用的文献
1
Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation.
Circ Res. 2014 Aug 15;115(5):525-32. doi: 10.1161/CIRCRESAHA.115.303881. Epub 2014 Jun 11.
2
Age-related remodeling of small arteries is accompanied by increased sphingomyelinase activity and accumulation of long-chain ceramides.
Physiol Rep. 2014 May 28;2(5). doi: 10.14814/phy2.12015. Print 2014 May 1.
3
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!
J Am Coll Cardiol. 2012 Sep 11;60(11):951-6. doi: 10.1016/j.jacc.2012.02.082.
4
Regulation of the human coronary microcirculation.
J Mol Cell Cardiol. 2012 Apr;52(4):814-21. doi: 10.1016/j.yjmcc.2011.10.003. Epub 2011 Oct 12.
5
Heart sphingolipids in health and disease.
Adv Exp Med Biol. 2011;721:41-56. doi: 10.1007/978-1-4614-0650-1_3.
6
Nitric oxide: orchestrator of endothelium-dependent responses.
Ann Med. 2012 Nov;44(7):694-716. doi: 10.3109/07853890.2011.585658. Epub 2011 Sep 7.
7
H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles.
Circ Res. 2011 Mar 4;108(5):566-73. doi: 10.1161/CIRCRESAHA.110.237636. Epub 2011 Jan 13.
8
Assessment of flow-mediated dilation in humans: a methodological and physiological guideline.
Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H2-12. doi: 10.1152/ajpheart.00471.2010. Epub 2010 Oct 15.
9
The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arteriolar diameter and structure.
Physiology (Bethesda). 2009 Feb;24:45-57. doi: 10.1152/physiol.00029.2008.
10
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.
Cardiovasc Res. 2009 May 1;82(2):175-83. doi: 10.1093/cvr/cvp030. Epub 2009 Jan 28.
Zotero 插件